Aktiia, a Swiss-US startup that develops optical blood pressure monitors at the wrist, has recently raised €5.6 million in funding. Switzerland-based Redalpine led the round along with strategically recruited international investor syndicate”: Translink Capital, Investiere, Libra, Christian Wenger, Sparks Street Capital, and Barbaric Holdings.
Michael Sidler, co-founder, and Partner of Redalpine say:
Getting blood pressure data 24/7, day and night is a paradigm shift in the daily management of hypertension and will trigger a whole range of novel health- and wellness-related applications.
Back in 2018, the company has raised a €3.7 million funding to bring its idea to life. As per the company claims, the Swiss-US startup is in the final steps of taking its new solution to market with FDA clearance and CE mark pending.
Aktiia was founded in Switzerland in May 2018 out of a passion for creating the best tool for diagnosis and treatment of hypertension. The company’s founders, Mattia Bertschi (CEO) and Josep Solà (CTO), previously contributed to research and development at CSEM, a prestigious Swiss research institute.